<DOC>
	<DOCNO>NCT00935064</DOCNO>
	<brief_summary>This study assess effect direct renin inhibition nerve function person diabetes use double-blind , placebo-controlled randomize trial involve two treatment arm ( i.e. , [ 1 ] 30 participant enrol randomized 300 mg Aliskiren ; [ 2 ] 30 participant enrol randomized placebo ) .</brief_summary>
	<brief_title>The Effect Renin Inhibition Nerve Function Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Individuals &gt; 18 year old type 1 type 2 diabetes mellitus . Individuals currently take maximum dose ACE inhibitor ARB . Individuals history MI , percutaneous coronary intervention , coronary artery bypass graft ( CABG ) surgery , acute coronary syndrome , recent/on go atrial fibrillation , frequent atrial arrhythmia , frequent ventricular arrhythmia , acute myocardial ischemia change . Individuals whose treatment dosage change 2 month prior study antihypertensive antidiabetes medication , follow medication may affect ANS : antituberculosis drug , nitrofurantoin , metronidazole , chloramphenicol , perhexiline maleate , amiodarone , clofibrate , tricyclic antidepressant , phenytoin , barbiturate , neuroleptic , antiparkinsonism drug , nitrate drug . Pregnant lactate female . Individuals impair renal function ( i.e. , creatinine &gt; 1.5 mg/dl ) , history dialysis , nephritic syndrome renovascular hypertension . Individuals potassium level within 0.5 mmol/L upper limit normal ( i.e. , hyperkalemia ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Diabetes</keyword>
</DOC>